anti- BCL2 antibody

anti- BCL2 antibody

Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor(APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release(PubMed:17418785).
Cat# Size Price Qty Buy
FNab00840 100µg £245.00

Additional Information

Property Value or Rating
Product Size 100µg
Manufacturer FineTest
Antibody Type monoclonal
Storage PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Physical Appearance liquid
Purification Protein A+G purification
Purity ≥95% as determined by SDS-PAGE
Host Mouse
Isotype IgG2a
Immunogen B-cell CLL/lymphoma 2
Alternate Names Apoptosis regulator Bcl 2, B cell CLL/lymphoma 2, BCL2, Oncogene B cell leukemia 2
Calculated MW 26 kDa
Protein ID P10415
Clone 8A10
Reactivity Human
Applications ELISA, IHC, IP, WB
Recommended dilution WB: 1:1000-1:10000; IP: 1:500-1:5000; IHC: 1:100-1:2000
Gene ID 596

Related Documents